Gaidhu Mandeep P, Perry Robert L S, Noor Fawad, Ceddia Rolando B
School of Kinesiology and Health Science, York University, Toronto, Ontario, Canada M3J1P3.
Mol Endocrinol. 2010 Jul;24(7):1434-40. doi: 10.1210/me.2009-0502. Epub 2010 May 25.
The aim of this study was to investigate the molecular mechanisms by which AMP-kinase (AMPK) activation inhibits basal and insulin-stimulated glucose uptake in primary adipocytes. Rat epididymal adipocytes were exposed to 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR) for 1 h. Subsequently, basal and insulin-stimulated glucose uptake and the phosphorylation of AMPK, acetyl-CoA carboxylase, Akt, and the Akt substrate of 160 kDa (AS160/TBC1D4) were determined. In order to investigate whether these effects of AICAR were mediated by AMPK activation, these parameters were also assessed in adipocytes either expressing LacZ (control) or a kinase-dead AMPKalpha1 mutant. AICAR increased AMPK activation without affecting basal and insulin-stimulated Akt1/2 phosphorylation on Thr(308) and Ser(473) residues. However, AMPK activation suppressed the phosphorylation of AS160/TBC1D4 and its interaction with the 14-3-3 signal transduction-regulatory protein, which was accompanied by significant reductions in plasma membrane glucose transporter 4 content and glucose uptake under basal and insulin-stimulated conditions. Phosphorylation of Akt substrates glycogen synthase kinase 3alpha and -beta were unaltered by AICAR, indicating that the AMPK-regulatory effects were specific to the AS160/TBC1D4 signaling pathway. Expression of the kinase-dead AMPKalpha1 mutant fully prevented the suppression of AS160/TBC1D4 phosphorylation, plasma membrane glucose transporter 4 content, and the inhibitory effect of AICAR-induced AMPK activation on basal and insulin-stimulated glucose uptake. This study is the first to provide evidence that disruption of AMPKalpha1 signaling prevents the suppressive effects of AMPK activation on AS160/TBC1D4 phosphorylation and glucose uptake, indicating that insulin-signaling steps that are common to white adipose tissue and skeletal muscle regulation of glucose uptake are distinctly affected by AMPK activation.
本研究的目的是探究AMP激酶(AMPK)激活抑制原代脂肪细胞基础葡萄糖摄取及胰岛素刺激的葡萄糖摄取的分子机制。将大鼠附睾脂肪细胞暴露于5-氨基咪唑-4-甲酰胺-1-β-D-呋喃核糖苷(AICAR)1小时。随后,测定基础葡萄糖摄取及胰岛素刺激的葡萄糖摄取,以及AMPK、乙酰辅酶A羧化酶、Akt和160 kDa的Akt底物(AS160/TBC1D4)的磷酸化水平。为了研究AICAR的这些作用是否由AMPK激活介导,还在表达LacZ(对照)或激酶失活的AMPKα1突变体的脂肪细胞中评估了这些参数。AICAR增加了AMPK的激活,而不影响基础状态下及胰岛素刺激下Akt1/2在苏氨酸(Thr)308和丝氨酸(Ser)473位点的磷酸化。然而,AMPK激活抑制了AS160/TBC1D4的磷酸化及其与14-3-3信号转导调节蛋白的相互作用,这伴随着基础状态下及胰岛素刺激条件下质膜葡萄糖转运蛋白4含量和葡萄糖摄取的显著降低。AICAR未改变Akt底物糖原合酶激酶3α和3β的磷酸化,表明AMPK的调节作用对AS160/TBC1D4信号通路具有特异性。激酶失活的AMPKα1突变体的表达完全阻止了AS160/TBC1D4磷酸化的抑制、质膜葡萄糖转运蛋白4含量的降低以及AICAR诱导的AMPK激活对基础葡萄糖摄取及胰岛素刺激的葡萄糖摄取的抑制作用。本研究首次提供证据表明,AMPKα1信号通路的破坏可防止AMPK激活对AS160/TBC1D4磷酸化和葡萄糖摄取的抑制作用,表明白色脂肪组织和骨骼肌调节葡萄糖摄取所共有的胰岛素信号步骤受到AMPK激活的明显影响。